Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CGM-based comparison of insulin glargine 300 U/mL versus insulin glargine 100 U/mL in adults with type 2 diabetes using basal insulin
RBR-35nvnjPhase 4Completed
- Sponsor
- CPClin
- Start
- Apr 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of insulin glargine in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by CPClin. Started Apr 2017; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on RBR-35nvnj.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-35nvnj.